CD44 and cancer: Mounting evidence has demonstrated that a subpopulation of cancer cells with positive CD44 and negative or low expression CD24 (CD44+/CD24−/low) are characterized by high tumorigenicity, as a few hundred of these cells were able to form solid tumors that was found to regain their parental heterogeneity into NOD/SCID mice [68].